Spect Scan
Showing 1 - 25 of 4,660
Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for
Recruiting
- Thyroid Gland Follicular Carcinoma
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Dementia, Parkinsonism, Mild Cognitive Impairment Trial in Rochester (I-123 Ioflupane solution injection prior to SPECT scan
Enrolling by invitation
- Dementia
- +3 more
- I-123 Ioflupane solution injection prior to SPECT scan (DaTscan)
- Single photon emission computed tomography (SPECT) scan
-
Rochester, MinnesotaMayo Clinic
Apr 25, 2022
Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed
Recruiting
- Prostate Carcinoma
- Recurrent Prostate Carcinoma
- 99mTc-based PSMA Imaging and Surgery Agent
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022
Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)
Recruiting
- Breast Cancer
- 99mTc-MY6349 SPECT/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)
Completed
- Primary Malignant Liver Neoplasm
- Computed Tomography (CT)
- +4 more
-
Palo Alto, CaliforniaStanford University
Dec 8, 2021
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single
Recruiting
- Hepatocellular Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Seattle, Washington
- +1 more
Feb 24, 2022
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor
Recruiting
- Metastatic Malignant Peripheral Nerve Sheath Tumor
- +2 more
- Computed Tomography
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 6, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Houston
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +4 more
- 6 Minute Walk Functional Test
- +6 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Lung Cancer, Radiation-Induced Disorder, Radiation Pneumonitis Trial in Sydney, Aarhus (Single-photon-emission CT scan)
Recruiting
- Lung Cancer
- +4 more
- Single-photon-emission CT scan
-
Sydney, New South Wales, Australia
- +1 more
May 18, 2022
Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,
Not yet recruiting
- Metastatic Colorectal Carcinoma
- +3 more
- Bevacizumab
- +11 more
- (no location specified)
May 9, 2023
NSCLC Trial in Ann Arbor (radiation, drug, device)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Response-driven Adaptive Radiation Therapy
- +5 more
-
Ann Arbor, Michigan
- +1 more
Dec 17, 2021
Pulmonary Embolism Trial in France, Switzerland (Planar V/Q-based strategy, CTPA-based strategy, V/Q SPECT-based strategy)
Recruiting
- Pulmonary Embolism
- Planar V/Q-based strategy
- +2 more
-
Agen, France
- +11 more
Jul 20, 2021
Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in
Recruiting
- Myelodysplastic Syndrome
- +16 more
- Computed Tomography
- +6 more
-
Scottsdale, Arizona
- +2 more
Feb 3, 2022
Neuroendocrine Tumors Trial in Ann Arbor (3-[18F]Fluoro-para-hydroxyphenethylguanidine, [123I] metaiodobenzylguanidine, Positron
Recruiting
- Neuroendocrine Tumors
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021
High Risk Prostate Cancer Trial in Turku (Whole body contrast enhanced computer tomography, 99mTC-HMDP planar bone scintigraphy
Completed
- High Risk Prostate Cancer
- Whole body contrast enhanced computer tomography
- +4 more
-
Turku, FinlandDepartment of Urology
May 3, 2022
Ventilation Homogeneity asMarker of Small Airway Disease in
Recruiting
- Lung Function Testing
- +4 more
- SPECT/CT
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Aug 3, 2021
Eosinophilic Esophagitis Trial in Salt Lake City (radiation, drug, procedure)
Completed
- Eosinophilic Esophagitis
- Computerized Tomography scan
- +4 more
-
Salt Lake City, UtahUniversity of Utah
Apr 29, 2021
Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)
Not yet recruiting
- Patients With Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA-617 PET scan
- (no location specified)
Nov 13, 2023
Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma Trial in Canada,
Recruiting
- Buccal Mucosa Squamous Cell Carcinoma
- +11 more
- Computed Tomography (CT)
- +5 more
-
Tucson, Arizona
- +71 more
Jan 11, 2023
Cancer Trial in Manchester (Y90-PET-CT scan)
Recruiting
- Cancer
- Y90-PET-CT scan
-
Manchester, United KingdomThe Christie NHS - Nuclear Medicine Department
Nov 7, 2023